Analyze Diet
Veterinary sciences2026; 13(7); 654; doi: 10.3390/vetsci13070654

Anti-Inflammatory and Metabolic Effects of Fresh Versus Freeze-Dried Platelet-Rich Plasma on Equine Osteoarthritis in an Ex Vivo Cartilage-Synovium Explant Co-Culture System: A Pilot Study.

Abstract: Equine osteoarthritis (OA) is a major cause of lameness and economic loss in horses. While platelet-rich plasma (PRP) has clinical potential, the biological effects of fresh PRP (F-PRP) and freeze-dried PRP (FD-PRP) remain insufficiently defined. This pilot study compared 25% and 50% F-PRP and FD-PRP in an interleukin-1β-induced equine cartilage-synovium explant co-culture model. PRP treatments reduced inflammatory responses, with significant downregulation of COX-2 and PGE2 expression, and 25% F-PRP showed the most consistent inhibition of nitric oxide production. PRP also significantly reduced glycosaminoglycan release and altered matrix-related gene expression; however, FD-PRP significantly upregulated , indicating a potential pro-catabolic response. Untargeted LC/MS metabolomics showed that F-PRP and FD-PRP were associated with changes in glucose, purine, amino acid, lipid, and nucleotide metabolism. Growth factor analysis further showed lower PDGF and TGF-β1 concentrations in FD-PRP than in F-PRP. Overall, F-PRP showed more consistent anti-inflammatory and matrix-protective effects, whereas FD-PRP requires further optimization and safety validation before clinical application.
Publication Date: 2026-07-06 PubMed ID: 42514664PubMed Central: PMC13431378DOI: 10.3390/vetsci13070654Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates and compares the anti-inflammatory and metabolic effects of fresh platelet-rich plasma (F-PRP) versus freeze-dried platelet-rich plasma (FD-PRP) on equine osteoarthritis using an ex vivo cartilage-synovium co-culture model.
  • The research aims to determine which form of PRP has greater potential therapeutic benefits for managing equine osteoarthritis and whether FD-PRP is a viable alternative to fresh preparations.

Background and Importance

  • Equine osteoarthritis (OA) is a prevalent cause of lameness in horses, resulting in significant welfare and economic concerns.
  • Platelet-rich plasma (PRP) has emerged as a promising treatment option due to its high concentration of growth factors and anti-inflammatory properties.
  • Fresh PRP (F-PRP) is commonly used clinically; however, the potential for freeze-dried PRP (FD-PRP) offers advantages such as longer shelf life and easier storage.
  • The biological effectiveness and safety profile of FD-PRP compared to F-PRP remain unclear, necessitating comparative studies.

Study Design and Methods

  • An ex vivo co-culture model involving equine cartilage and synovium explants was employed to simulate osteoarthritic joint conditions.
  • Osteoarthritis was induced by treatment with interleukin-1β (IL-1β), a pro-inflammatory cytokine involved in OA pathogenesis.
  • Treatments included 25% and 50% concentrations of both F-PRP and FD-PRP to test dose-related effects.
  • Outcomes measured included inflammatory markers (COX-2, PGE2, nitric oxide), matrix degradation markers (glycosaminoglycan release), and gene expression related to cartilage matrix and catabolism.
  • Metabolic profiling was conducted using untargeted liquid chromatography-mass spectrometry (LC/MS) to assess broader biochemical changes induced by PRP treatments.
  • Growth factor levels, notably platelet-derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-β1), were quantified in both PRP types.

Key Findings

  • Both F-PRP and FD-PRP reduced inflammatory responses in the IL-1β-induced explants as evidenced by the downregulation of cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) expression.
  • Among the treatments, 25% concentration of F-PRP was particularly effective in consistently inhibiting nitric oxide production, an important inflammatory mediator.
  • PRP treatment generally reduced the release of glycosaminoglycans, indicating a protective effect against cartilage matrix breakdown.
  • Despite these benefits, FD-PRP significantly upregulated certain markers (not fully detailed in the abstract), suggestive of a possible pro-catabolic or matrix-degrading response, a potential safety concern.
  • Metabolomic analysis revealed that both PRP types influenced metabolic pathways linked to glucose, purine, amino acid, lipid, and nucleotide metabolism, highlighting complex biochemical effects beyond simple inflammatory changes.
  • Growth factor assays showed that FD-PRP contained lower concentrations of PDGF and TGF-β1 compared to F-PRP, which may partly explain the differences in biological activity and efficacy between the two forms.

Conclusions and Implications

  • Fresh PRP demonstrated more consistent anti-inflammatory and cartilage matrix-protective effects in the equine OA model.
  • Freeze-dried PRP, while showing some anti-inflammatory properties, induced potentially harmful pro-catabolic responses and had reduced growth factor levels.
  • These findings suggest that FD-PRP currently requires further optimization to improve its safety and biological efficacy before it can be recommended for clinical application in equine OA.
  • The pilot nature of this study indicates that larger-scale and in vivo studies are needed to validate these results and explore the mechanisms underlying observed differences.

Significance for Veterinary Medicine and Future Directions

  • This work enhances understanding of PRP formulations’ biological effects in equine joint disease, aiding veterinarians in making informed treatment decisions.
  • Optimizing FD-PRP could lead to more practical and accessible therapies for OA with improved shelf life and ease of use.
  • Future research should explore ways to preserve or restore growth factor concentrations in FD-PRP and monitor long-term safety and efficacy in live animals.
  • Integration of metabolomics provides a novel approach to monitor treatment impact and potentially discover biomarkers for therapy response.

Cite This Article

APA
Duan S, Wang Z, Jia Y, Lan X, Peng C, Deng X, Jiang H, Wang W, Zhong G, Zhu Y, Li J. (2026). Anti-Inflammatory and Metabolic Effects of Fresh Versus Freeze-Dried Platelet-Rich Plasma on Equine Osteoarthritis in an Ex Vivo Cartilage-Synovium Explant Co-Culture System: A Pilot Study. Vet Sci, 13(7), 654. https://doi.org/10.3390/vetsci13070654

Publication

ISSN: 2306-7381
NlmUniqueID: 101680127
Country: Switzerland
Language: English
Volume: 13
Issue: 7
PII: 654

Researcher Affiliations

Duan, Shiyu
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Wang, Zixuan
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
  • State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Jia, Yuchen
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Lan, Xin'er
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Peng, Cong
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Deng, Xiyue
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Jiang, Hui
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Wang, Wei
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Zhong, Guangzhi
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Zhu, Yiping
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
  • State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Li, Jing
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
  • State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.

Grant Funding

  • ZZYD2025010 / Xinjiang Talent Development Fund

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 63 references
  1. Sharma L. Osteoarthritis of the Knee. N. Engl. J. Med. 2021;384:51–59.
    doi: 10.1056/NEJMcp1903768pubmed: 33406330google scholar: lookup
  2. Boden L.A., Anderson G.A., Charles J.A., Morgan K.L., Morton J.M., Parkin T.D.H., Slocombe R.F., Clarke A.F.. Risk of Fatality and Causes of Death of Thoroughbred Horses Associated with Racing in Victoria, Australia: 1989–2004. Equine Vet. J. 2006;38:312–318.
    doi: 10.2746/042516406777749182pubmed: 16866197google scholar: lookup
  3. Dabareiner R.M., Cohen N.D., Carter G.K., Nunn S., Moyer W. Musculoskeletal Problems Associated with Lameness and Poor Performance among Horses Used for Barrel Racing: 118 Cases (2000–2003). J. Am. Vet. Med. Assoc. 2005;227:1646–1650.
    doi: 10.2460/javma.2005.227.1646pubmed: 16313045google scholar: lookup
  4. Ireland J.L., Clegg P.D., McGowan C.M., Platt L., Pinchbeck G.L.. Factors Associated with Mortality of Geriatric Horses in the United Kingdom. Prev. Vet. Med. 2011;101:204–218.
  5. Reed S.R., Jackson B.F., Mc Ilwraith C.W., Wright I.M., Pilsworth R., Knapp S., Wood J.L.N., Price J.S., Verheyen K.L.P.. Descriptive Epidemiology of Joint Injuries in Thoroughbred Racehorses in Training. Equine Vet. J. 2012;44:13–19.
  6. Zanotto G.M., Frisbie D.D.. Current Joint Therapy Usage in Equine Practice: Changes in the Last 10 Years. Equine Vet. J. 2022;54:750–756.
    doi: 10.1111/evj.13489pubmed: 34143532google scholar: lookup
  7. McAlindon T.E., LaValley M.P., Harvey W.F., Price L.L., Driban J.B., Zhang M., Ward R.J.. Effect of Intra-Articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA 2017;317:1967.
    doi: 10.1001/jama.2017.5283pmc: PMC5815012pubmed: 28510679google scholar: lookup
  8. Camargo Garbin L., Morris M.J.. A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution for Treatment of Osteoarthritis in Horses. Front. Vet. Sci. 2021;8:602978.
    doi: 10.3389/fvets.2021.602978pmc: PMC7933025pubmed: 33681323google scholar: lookup
  9. Da Silva Xavier A.A., Da Rosa P.P., De Brum Mackmill L., Roll V.F.B.. An Assessment of the Effectiveness of Hyaluronic Acid and Polyacrylamide Hydrogel in Horses with Osteoarthritis: Systematic Review and Network Meta-Analysis. Res. Vet. Sci. 2021;134:42–50.
    doi: 10.1016/j.rvsc.2020.11.013pubmed: 33290979google scholar: lookup
  10. Shimizu S., Asou Y., Itoh S., Chung U., Kawaguchi H., Shinomiya K., Muneta T.. Prevention of Cartilage Destruction with Intraarticular Osteoclastogenesis Inhibitory Factor/Osteoprotegerin in a Murine Model of Osteoarthritis. Arthritis Rheum. 2007;56:3358–3365.
    doi: 10.1002/art.22941pubmed: 17907189google scholar: lookup
  11. Sundman E.A., Cole B.J., Karas V., Della Valle C., Tetreault M.W., Mohammed H.O., Fortier L.A.. The Anti-Inflammatory and Matrix Restorative Mechanisms of Platelet-Rich Plasma in Osteoarthritis. Am. J. Sports Med. 2014;42:35–41.
    doi: 10.1177/0363546513507766pubmed: 24192391google scholar: lookup
  12. Jacobs C.C., Schnabel L.V., McIlwraith C.W., Blikslager A.T.. Non-steroidal Anti-inflammatory Drugs in Equine Orthopaedics. Equine Vet. J. 2022;54:636–648.
    doi: 10.1111/evj.13561pmc: PMC9304133pubmed: 35076950google scholar: lookup
  13. Garbin L.C., Olver C.S.. Platelet-Rich Products and Their Application to Osteoarthritis. J. Equine Vet. Sci. 2020;86:102820.
    doi: 10.1016/j.jevs.2019.102820pubmed: 32067662google scholar: lookup
  14. Szwedowski D., Szczepanek J., Paczesny Ł., Zabrzyński J., Gagat M., Mobasheri A., Jeka S.. The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis. Int. J. Mol. Sci. 2021;22:5492.
    doi: 10.3390/ijms22115492pmc: PMC8197096pubmed: 34071037google scholar: lookup
  15. Hersant B., Sid-Ahmed M., Braud L., Jourdan M., Baba-Amer Y., Meningaud J.-P., Rodriguez A.-M.. Platelet-Rich Plasma Improves the Wound Healing Potential of Mesenchymal Stem Cells through Paracrine and Metabolism Alterations. Stem Cells Int. 2019;2019:1234263.
    doi: 10.1155/2019/1234263pmc: PMC6875194pubmed: 31781232google scholar: lookup
  16. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of Platelet-derived Growth Factor in Wound Healing. J. Cell. Biochem. 1991;45:319–326.
    doi: 10.1002/jcb.240450403pubmed: 2045423google scholar: lookup
  17. Cardona-Ramírez S, Wolfe PN, Correa-Valencia NM. Intra-Articular Use of Platelet-Rich Plasma and Its Derivatives in Canine Osteoarthritis: A Systematic Review. J. Am. Vet. Med. Assoc. 2025;263:1434–1443.
    doi: 10.2460/javma.25.01.0033pubmed: 40912277google scholar: lookup
  18. Carmona JU, López C. Platelet-Rich Plasma in Equine Osteoarthritis: A Systematic Review of Clinical and Experimental Evidence. Animals 2025;15:2647.
    doi: 10.3390/ani15182647pmc: PMC12466402pubmed: 41007891google scholar: lookup
  19. Kim JI, Bae HC, Park HJ, Lee MC, Han HS. Effect of Storage Conditions and Activation on Growth Factor Concentration in Platelet-Rich Plasma. J. Orthop. Res. 2020;38:777–784.
    doi: 10.1002/jor.24520pubmed: 31709604google scholar: lookup
  20. Andia I, Perez-Valle A, Del Amo C, Maffulli N. Freeze-Drying of Platelet-Rich Plasma: The Quest for Standardization. Int. J. Mol. Sci. 2020;21:6904.
    doi: 10.3390/ijms21186904pmc: PMC7555364pubmed: 32962283google scholar: lookup
  21. Caron MMJ, Emans PJ, Coolsen MME, Voss L, Surtel DAM, Cremers A, Van Rhijn LW, Welting TJM. Redifferentiation of Dedifferentiated Human Articular Chondrocytes: Comparison of 2D and 3D Cultures. Osteoarthr. Cartil. 2012;20:1170–1178.
    doi: 10.1016/j.joca.2012.06.016pubmed: 22796508google scholar: lookup
  22. Rydén M, Önnerfjord P. In Vitro Models and Proteomics in Osteoarthritis Research. Adv. Exp. Med. Biol. 2023;1402:57–68.
    doi: 10.1007/978-3-031-25588-5_4pubmed: 37052846google scholar: lookup
  23. Hsueh M-F, Khabut A, Kjellström S, Önnerfjord P, Kraus VB. Elucidating the Molecular Composition of Cartilage by Proteomics. J. Proteome Res. 2016;15:374–388.
  24. Anderson JR, Phelan MM, Foddy L, Clegg PD, Peffers MJ. Ex Vivo Equine Cartilage Explant Osteoarthritis Model: A Metabolomics and Proteomics Study. J. Proteome Res. 2020;19:3652–3667.
  25. Velloso Alvarez A, Boone LH, Pondugula SR, Caldwell F, Wooldridge AA. Effects of Autologous Conditioned Serum, Autologous Protein Solution, and Triamcinolone on Inflammatory and Catabolic Gene Expression in Equine Cartilage and Synovial Explants Treated With IL-1β in Co-Culture. Front. Vet. Sci. 2020;7:323.
    doi: 10.3389/fvets.2020.00323pmc: PMC7332692pubmed: 32671108google scholar: lookup
  26. Sharun K, Banu SA. Minimum Reporting Guidelines for Platelet-Rich Plasma in Veterinary Regenerative Medicine. Vet. Res. Commun. 2025;49:111.
    doi: 10.1007/s11259-025-10690-3pubmed: 39985602google scholar: lookup
  27. Kon E, Di Matteo B, Delgado D, Cole BJ, Dorotei A, Dragoo JL, Filardo G, Fortier LA, Giuffrida A, Jo CH. Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: An Expert Opinion and Proposal for a Novel Classification and Coding System. Expert Opin. Biol. Ther. 2020;20:1447–1460.
    doi: 10.1080/14712598.2020.1798925pubmed: 32692595google scholar: lookup
  28. Haltmayer E, Ribitsch I, Gabner S, Rosser J, Gueltekin S, Peham J, Giese U, Dolezal M, Egerbacher M, Jenner F. Co-Culture of Osteochondral Explants and Synovial Membrane as in Vitro Model for Osteoarthritis. PLoS ONE 2019;14:e0214709.
  29. Tang S, Deng S, Guo J, Chen X, Zhang W, Cui Y, Luo Y, Yan Z, He Q-Y, Shen S. Deep Coverage Tissue and Cellular Proteomics Revealed IL-1β Can Independently Induce the Secretion of TNF-Associated Proteins from Human Synoviocytes. J. Immunol. 2018;200:821–833.
    doi: 10.4049/jimmunol.1700480pubmed: 29196456google scholar: lookup
  30. Lepetsos P, Papavassiliou AG. ROS/Oxidative Stress Signaling in Osteoarthritis. Biochim. Biophys. Acta BBA-Mol. Basis Dis. 2016;1862:576–591.
    doi: 10.1016/j.bbadis.2016.01.003pubmed: 26769361google scholar: lookup
  31. Scher JU, Pillinger MH, Abramson SB. Nitric Oxide Synthases and Osteoarthritis. Curr. Rheumatol. Rep. 2007;9:9–15.
    doi: 10.1007/s11926-007-0016-zpubmed: 17437661google scholar: lookup
  32. Vuolteenaho K, Moilanen T, Hämäläinen M, Moilanen E. Regulation of Nitric Oxide Production in Osteoarthritic and Rheumatoid cartilageRole of Endogenous IL-1 Inhibitors. Scand. J. Rheumatol. 2003;32:19–24.
    doi: 10.1080/03009740310000355pubmed: 12635941google scholar: lookup
  33. Simon LS. Role and Regulation of Cyclooxygenase-2 during Inflammation. Am. J. Med. 1999;106:37S–42S.
    doi: 10.1016/S0002-9343(99)00115-1pubmed: 10390126google scholar: lookup
  34. Claveau D, Sirinyan M, Guay J, Gordon R, Chan C-C, Bureau Y, Riendeau D, Mancini JA. Microsomal Prostaglandin E Synthase-1 Is a Major Terminal Synthase That Is Selectively Up-Regulated During Cyclooxygenase-2-Dependent Prostaglandin E2 Production in the Rat Adjuvant-Induced Arthritis Model. J. Immunol. 2003;170:4738–4744.
    doi: 10.4049/jimmunol.170.9.4738pubmed: 12707354google scholar: lookup
  35. Saxne T, Heinegård D. Cartilage Oligomeric Matrix Protein: A Novel Marker of Cartilage Turnover Detectable in Synovial Fluid and Blood. Rheumatology 1992;31:583–591.
    doi: 10.1093/rheumatology/31.9.583pubmed: 1381980google scholar: lookup
  36. Koelling S, Clauditz TS, Kaste M, Miosge N. Cartilage Oligomeric Matrix Protein Is Involved in Human Limb Development and in the Pathogenesis of Osteoarthritis. Arthritis Res. Ther. 2006;8:R56.
    doi: 10.1186/ar1922pmc: PMC1526624pubmed: 16542502google scholar: lookup
  37. Mehana E-SE, Khafaga AF, El-Blehi SS. The Role of Matrix Metalloproteinases in Osteoarthritis Pathogenesis: An Updated Review. Life Sci. 2019;234:116786.
    doi: 10.1016/j.lfs.2019.116786pubmed: 31445934google scholar: lookup
  38. Neuhold LA, Killar L, Zhao W, Sung M-LA, Warner L, Kulik J, Turner J, Wu W, Billinghurst C, Meijers T. Postnatal Expression in Hyaline Cartilage of Constitutively Active Human Collagenase-3 (MMP-13) Induces Osteoarthritis in Mice. J. Clin. Investig. 2001;107:35–44.
    doi: 10.1172/JCI10564pmc: PMC198546pubmed: 11134178google scholar: lookup
  39. Ohanian M, Cancelas JA, Davenport R, Pullarkat V, Hervig T, Broome C, Marek K, Kelly M, Gul Z, Rugg N. Freeze-Dried Platelets Are a Promising Alternative in Bleeding Thrombocytopenic Patients with Hematological Malignancies. Am. J. Hematol. 2022;97:256–266.
    doi: 10.1002/ajh.26403pubmed: 34748664google scholar: lookup
  40. Nakajima R, Saita Y, Kobayashi Y, Wakayama T, Uchino S, Momoi Y, Yamamoto N, Ishijima M. Comparison of Bioactive Substances in Novel-Developed Freeze-Dried Platelet-Rich Plasma (PRP) and Activated Normal PRP, and Investigation of Bioactive Substance Levels after Long-Term Storage. Regen. Ther. 2024;27:200–206.
    doi: 10.1016/j.reth.2024.03.021pmc: PMC10990710pubmed: 38571893google scholar: lookup
  41. Kwirant LADA, De La Corte FD, Cantarelli C, Cargnelutti JF, Martins M, Cabral MW, Maciel N, Rubin MIB. Cooling and Cryopreservation of Equine Platelet-Rich Plasma With Dimethyl Sulfoxide and Trehalose. J. Equine Vet. Sci. 2019;72:112–116.
    doi: 10.1016/j.jevs.2018.10.009pubmed: 30929774google scholar: lookup
  42. Pietramaggiori G, Kaipainen A, Ho D, Orser C, Pebley W, Rudolph A, Orgill DP. Trehalose Lyophilized Platelets for Wound Healing. Wound Repair Regen. 2007;15:213–220.
  43. Mastbergen SC, Bijlsma JWJ, Lafeber FPJG. Synthesis and Release of Human Cartilage Matrix Proteoglycans Are Differently Regulated by Nitric Oxide and Prostaglandin-E2. Ann. Rheum. Dis. 2008;67:52–58.
    doi: 10.1136/ard.2006.065946pubmed: 17485421google scholar: lookup
  44. Al-Omran A, Parvathy SS. Role of Nitric Oxide in Inflammatory Diseases. Inflammopharmacology 2007;15:252–259.
    doi: 10.1007/s10787-007-0013-xpubmed: 18236016google scholar: lookup
  45. Araujo-Gutierrez R, Van Eps JL, Scherba JC, Anastasio AT, Cabrera F, Vatsaas CJ, Youker K, Fernandez Moure JS. Platelet Rich Plasma Concentration Improves Biologic Mesh Incorporation and Decreases Multinucleated Giant Cells in a Dose Dependent Fashion. J. Tissue Eng. Regen. Med. 2021;15:1037–1046.
    doi: 10.1002/term.3247pubmed: 34551456google scholar: lookup
  46. Peng C, Yang L, Labens R, Gao Y, Zhu Y, Li J. A Systematic Review and Meta-Analysis of the Efficacy of Platelet-Rich Plasma Products for Treatment of Equine Joint Disease. Equine Vet. J. 2024;56:858–869.
    doi: 10.1111/evj.14042pubmed: 38185481google scholar: lookup
  47. Dragoo JL, Danial CM, Braun HJ, Pouliot MA, Kim HJ. The Chondrotoxicity of Single-dose Corticosteroids. Knee Surg. Sports Traumatol. Arthrosc. 2012;20:1809–1814.
    doi: 10.1007/s00167-011-1820-6pubmed: 22186921google scholar: lookup
  48. Kearney CM, Korthagen NM, Plomp SGM, Labberté MC, De Grauw JC, Van Weeren PR, Brama PAJ. Treatment Effects of Intra-articular Triamcinolone Acetonide in an Equine Model of Recurrent Joint Inflammation. Equine Vet. J. 2021;53:1277–1286.
    doi: 10.1111/evj.13396pubmed: 33280164google scholar: lookup
  49. Van Buul GM, Koevoet WLM, Kops N, Bos PK, Verhaar JAN, Weinans H, Bernsen MR, Van Osch GJVM. Platelet-Rich Plasma Releasate Inhibits Inflammatory Processes in Osteoarthritic Chondrocytes. Am. J. Sports Med. 2011;39:2362–2370.
    doi: 10.1177/0363546511419278pubmed: 21856929google scholar: lookup
  50. Posey KL, Coustry F, Hecht JT. Cartilage Oligomeric Matrix Protein: COMPopathies and Beyond. Matrix Biol. 2018;71–72:161–173.
  51. Wang M, Sampson ER, Jin H, Li J, Ke QH, Im H-J, Chen D. MMP13 Is a Critical Target Gene during the Progression of Osteoarthritis. Arthritis Res. Ther. 2013;15:R5.
    doi: 10.1186/ar4133pmc: PMC3672752pubmed: 23298463google scholar: lookup
  52. Martínez-Reyes I, Chandel NS. Mitochondrial TCA Cycle Metabolites Control Physiology and Disease. Nat. Commun. 2020;11:102.
    doi: 10.1038/s41467-019-13668-3pmc: PMC6941980pubmed: 31900386google scholar: lookup
  53. Zheng L, Zhang Z, Sheng P, Mobasheri A. The Role of Metabolism in Chondrocyte Dysfunction and the Progression of Osteoarthritis. Ageing Res. Rev. 2021;66:101249.
    doi: 10.1016/j.arr.2020.101249pubmed: 33383189google scholar: lookup
  54. Zhang W, Sun G, Likhodii S, Liu M, Aref-Eshghi E, Harper PE, Martin G, Furey A, Green R, Randell E. Metabolomic Analysis of Human Plasma Reveals That Arginine Is Depleted in Knee Osteoarthritis Patients. Osteoarthr. Cartil. 2016;24:827–834.
    doi: 10.1016/j.joca.2015.12.004pubmed: 26708258google scholar: lookup
  55. Carmona JU, Ríos DL, López C, Álvarez ME, Pérez JE, Bohórquez ME. In Vitro Effects of Platelet-Rich Gel Supernatants on Histology and Chondrocyte Apoptosis Scores, Hyaluronan Release and Gene Expression of Equine Cartilage Explants Challenged with Lipopolysaccharide. BMC Vet. Res. 2016;12:135.
    doi: 10.1186/s12917-016-0759-8pmc: PMC4929746pubmed: 27369779google scholar: lookup
  56. Požgan U, Caglič D, Rozman B, Nagase H, Turk V, Turk B. Expression and Activity Profiling of Selected Cysteine Cathepsins and Matrix Metalloproteinases in Synovial Fluids from Patients with Rheumatoid Arthritis and Osteoarthritis. Biol. Chem. 2010;391:571–579.
    doi: 10.1515/bc.2010.035pubmed: 20180636google scholar: lookup
  57. Gilbert SJ, Bonnet CS, Blain EJ. Mechanical Cues: Bidirectional Reciprocity in the Extracellular Matrix Drives Mechano-Signalling in Articular Cartilage. Int. J. Mol. Sci. 2021;22:13595.
    doi: 10.3390/ijms222413595pmc: PMC8707858pubmed: 34948394google scholar: lookup
  58. Blicharski T, Tomaszewska E, Dobrowolski P, Hułas-Stasiak M, Muszyński S. A Metabolite of Leucine (β-Hydroxy-β-Methylbutyrate) given to Sows during Pregnancy Alters Bone Development of Their Newborn Offspring by Hormonal Modulation. PLoS ONE 2017;12:e0179693.
  59. Cronstein BN, Angle SR. Purines and Adenosine Receptors in Osteoarthritis. Biomolecules 2023;13:1760.
    doi: 10.3390/biom13121760pmc: PMC10741532pubmed: 38136631google scholar: lookup
  60. Laus F, Gialletti R, Bazzano M, Laghi L, Dini F, Marchegiani A. Synovial Fluid Metabolome Can Differentiate between Healthy Joints and Joints Affected by Osteoarthritis in Horses. Metabolites 2023;13:913.
    doi: 10.3390/metabo13080913pmc: PMC10456394pubmed: 37623857google scholar: lookup
  61. Mustonen A-M, Lehmonen N, Paakkonen T, Raekallio M, Käkelä R, Niemelä T, Mykkänen A, Sihvo SP, Nieminen P. Equine Osteoarthritis Modifies Fatty Acid Signatures in Synovial Fluid and Its Extracellular Vesicles. Arthritis Res. Ther. 2023;25:39.
    doi: 10.1186/s13075-023-02998-9pmc: PMC9996872pubmed: 36895037google scholar: lookup
  62. Wang T, He C. Pro-Inflammatory Cytokines: The Link between Obesity and Osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38–50.
    doi: 10.1016/j.cytogfr.2018.10.002pubmed: 30340925google scholar: lookup
  63. Gilbertie JM, Long JM, Schubert AG, Berglund AK, Schaer TP, Schnabel LV. Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators. Front. Vet. Sci. 2018;5:150.
    doi: 10.3389/fvets.2018.00150pmc: PMC6039577pubmed: 30023361google scholar: lookup

Citations

This article has been cited 0 times.